Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Open Biosystems

2001 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Developer of RNA interference, gene expression and protein detection products for life science research and drug discovery and development. The company offers genomic research tools to scientists and researchers in corporate, academic and government laboratories.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Acquirer
Primary Office
  • 2650 Crescent Drive
  • Suite 100
  • Lafayette, CO 80026
  • United States

+1 (800) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Open Biosystems’s full profile, request a free trial.

Open Biosystems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jul-2008 Completed
1. Early Stage VC Completed
To view this company’s complete deal history including valuation and funding, request access »

Open Biosystems Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Advantage Capital (St. Louis) Venture Capital Minority 000 0000 000000 0

Open Biosystems Executive Team (7)

Name Title Board
Seat
Contact
Info
David Kloske Director, Information Technology
Matt Baker Vice President, Proteomics & Business Development
Woody Woodward Vice President, Sales & Marketing
Pete Yanul Chief Financial Officer
Blake Simmons Director, Operations

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »